FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

716125002: Pembrolizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3304810011 Pembrolizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3304811010 Pembrolizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
55781000195113 pembrolizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
831751000172113 pembrolizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
70861000195116 Pembrolizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pembrolizumab (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Pembrolizumab (substance) Is a agent d'anticorps monoclonal false Inferred relationship Some
Pembrolizumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Pembrolizumab (substance) Is a Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) true Inferred relationship Some
Pembrolizumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Programmed cell death protein 1 inhibitor (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing pembrolizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pembrolizumab (substance) Inferred relationship Some 1
Product containing pembrolizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pembrolizumab (substance) Inferred relationship Some 1
Product containing only pembrolizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pembrolizumab (substance) Inferred relationship Some 1
Product containing only pembrolizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pembrolizumab (substance) Inferred relationship Some 1
Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pembrolizumab (substance) Inferred relationship Some 1
Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pembrolizumab (substance) Inferred relationship Some 1
Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pembrolizumab (substance) Inferred relationship Some 1
Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pembrolizumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start